Welcome to My Blog
Here is a masonry blog layout with no sidebarReliance partners with Google, FB for digital payment network bid: Report
16,752 new Covid-19 cases reported,6 states continue to witness surge
COVID-19 crisis far from over; 3rd wave to be more dangerous: CSIR officia
Mobile app improves price data collection, says govt
The department is also utilising the services of Agriwatch for providing market intelligence, predictive analysis of prices and to develop price forecasting model. The department said it had proposed to DEA (department of economic affairs) for technical assistance fund under CARES Progamme of Asian Development Bank (ADB) for improving price monitoring and analysis.
Pvt health insurers offering 80-100 pc discounts on renewal premia for healthy customers
Blood tests offer early indicator of severe Covid: Study
Govt fixes Covid vaccine price at Rs 250 a shot for pvt hospitals
The Union Government has fixed the price of vaccines at Rs 250 for a dose which would be available at private hospitals for people above 60 years of age and those above 45 years of age with comorbidities, and will be vaccinated starting March 1, sources said.
The government has decided that the people will be vaccinated free of cost at the government hospitals.
The cost break-up is Rs 150 for a dose plus Rs 100 as a service charge which the private facilities can charge from the beneficiaries.
Rare Disease Day: Health advocacy groups press for govt policy, say India’s numbers unknown
Rare diseases, including genetic disorders such as Hunter syndrome, Gaucher disease and Fabry’s disease, are expensive to treat, difficult to identify and extract a huge toll, mostly on the young, the experts said ahead of Rare Disease Day on Sunday.
Rare diseases are also not covered by insurance policies. It is imperative the government steps in to help these patients so they can lead a near normal life, Health groups in India said.
They have also urged the government to make newborn screening mandatory to be able to identify genetical problems at an early stage. The monthly treatment cost of such diseases can be anywhere between Rs 10 lakh and Rs 50 lakh, they said.
UK health insurers’ profitability still strong despite coronavirus disruption:Fitch
Fintech players get $2.7 bn from VCs in 2020: Report
S&P insurers moving cautiously in the aftermath of massive Texas Ice storm Uri
Specialty insurer and reinsurer SiriusPoint launches with over $3bn in capital
“We aspire to be a disruptive force in the industry and drive technology innovation – with skilled underwriting at the core of everything we do. We have set a goal to challenge the status quo and define new ways of conducting business with diversity of thought and expertise. I am very excited about our future. We are building a company and a culture we can be proud of.”
Govt sets 50 lakh users threshold to define ‘significant social media intermediary’ under IT rules
IMF, World Bank pledge to support G20 push against global climate risks
World Bank President Malpass told finance officials from the Group of 20 economies that the Bank, the biggest provider of climate finance to the developing world, would make record climate investments for a second consecutive year in 2021.
“A key focus will be to help countries achieve a just transition from coal to affordable, reliable, and sustainable energy. We are also developing a framework for fiscal policy and sustainable growth, including carbon taxation and its redistributive impact,” he said.
Oxford University says research not affected after media reports of COVID lab hack
“We have identified and contained the problem and are now investigating further. There has been no impact on any clinical research, as this is not conducted in the affected area,” an Oxford spokesman said, adding that the university was working with the National Cyber Security Centre (NCSC) on the incident.
Govt plans two-day halt in vaccinations for software upgrade to widen campaign
“The countrywide vaccination exercise is being exponentially expanded,” the ministry said in a statement, adding that a new version of its Co-Win digital platform was being rolled out at the weekend.
Co-Win, wrapped into a government mobile telephone app, is being widely used to fix vaccination appointments, allow health authorities to monitor supplies and download proof of immunisation.
Global insurers unite to tackle climate risk with launch of Geneva Association Task Force
Jad Ariss, Geneva Association Managing Director, said: “In 2020 alone, the world witnessed massive wildfires in California and Australia, historic floods in China and a record hurricane season in the Atlantic. The societal impacts of climate change have become ubiquitous, and individuals and institutions must fully commit now to confronting the climate crisis. Insurers are obvious, strong leaders on global climate action, given their core functions – managing risk and investing – and our industry-led initiative demonstrates that they are proactively rising to the occasion.”
Indians allowed to choose vaccination sites as government seeks faster roll-out
But the inoculation campaign has progressed slower than expected due to a reluctance of health and front-line workers to take the home-grown COVAXIN shot that was approved without late-stage efficacy data. Only 11% of vaccinated people have opted for the product developed by Bharat Biotech and the state-run Indian Council of Medical Research.
With the world’s highest tally of infections after the United States, India wants to vaccinate 300 million of its 1.35 billion people by August. The decision to give people a choice of vaccines could now speed up the roll-out, officials believe.